Phase IV research encompasses all clinical studies conducted after a medication receives regulatory approval. Unlike pre-approval trials, which follow rigid protocols to answer specific regulatory questions, Phase IV studies employ diverse designs—from traditional randomized controlled trials to observational analyses of electronic health records—to answer the broader clinical questions that emerge once a medication enters routine practice.

Phase IV represents the largest and most methodologically diverse phase of drug development, drawing on epidemiology, comparative effectiveness research, and real-world data science in ways that earlier phases do not.

Phase IV research encompasses all clinical studies conducted after a medication receives regulatory approval. Unlike pre-approval trials, which follow rigid protocols to answer specific regulatory questions, Phase IV studies employ diverse designs—from traditional randomized controlled trials to observational analyses of electronic health records—to answer the broader clinical questions that emerge once a medication enters routine practice.

Phase IV represents the largest and most methodologically diverse phase of drug development, drawing on epidemiology, comparative effectiveness research, and real-world data science in ways that earlier phases do not.